May 1998
Volume 39, Issue 6
Free
Articles  |   May 1998
Costimulatory molecules in ocular cicatricial pemphigoid.
Author Affiliations
  • N Tesavibul
    Uveitis and Immunology Service, Massachusetts Eye and Ear Infirmary, Boston 02114, USA.
  • D Dorfman
    Uveitis and Immunology Service, Massachusetts Eye and Ear Infirmary, Boston 02114, USA.
  • V S Sangwan
    Uveitis and Immunology Service, Massachusetts Eye and Ear Infirmary, Boston 02114, USA.
  • W Christen
    Uveitis and Immunology Service, Massachusetts Eye and Ear Infirmary, Boston 02114, USA.
  • Z Panayotis
    Uveitis and Immunology Service, Massachusetts Eye and Ear Infirmary, Boston 02114, USA.
  • B Rojas
    Uveitis and Immunology Service, Massachusetts Eye and Ear Infirmary, Boston 02114, USA.
  • C S Foster
    Uveitis and Immunology Service, Massachusetts Eye and Ear Infirmary, Boston 02114, USA.
Investigative Ophthalmology & Visual Science May 1998, Vol.39, 982-988. doi:
  • Views
  • PDF
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      N Tesavibul, D Dorfman, V S Sangwan, W Christen, Z Panayotis, B Rojas, C S Foster; Costimulatory molecules in ocular cicatricial pemphigoid.. Invest. Ophthalmol. Vis. Sci. 1998;39(6):982-988.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
This content is PDF only. Please click on the PDF icon to access.
Abstract

PURPOSE: To examine normal and inflamed conjunctiva from patients with ocular cicatricial pemphigoid (OCP) for the presence of costimulatory molecule CD28 and its ligands B7-1 (CD80) and B7-2 (CD86). METHODS: Conjunctival biopsy specimens from 12 patients with OCP and from five healthy persons undergoing cataract surgery were analyzed by light microscopy and immunohistochemical examination with monoclonal antibody probes for CD28, B7-1, and B7-2 molecules and for mononuclear cell subtypes. RESULTS: Epithelium of OCP conjunctiva showed more Langerhans' cells, B7-1-positive (+) cells, and B7-2 expression (ratio of B7-2-positive cells to antigen-presenting cells). In the substantia propria, OCP specimens showed significantly increased numbers of T cells (CD3 +), macrophages (CD68+), CD28+ cells, B7-2+ cells (CD86+), Langerhans' cells (CD1a), and B7-1+ cells (CD80). Most of the B7-2+ cells, macrophages, and Langerhans' cells were located subepithelially. B7-2 expression was significantly higher in OCP conjunctival substantia propria compared with normal conjunctiva. CONCLUSIONS: The results of this study indicate that the expression of the costimulatory molecule B7-2 is upregulated in conjunctiva of patients with active OCP. This increased subepithelial B7-2 expression may contribute to the sustained immune activation in OCP conjunctiva.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×